Connect Biopharma Holdings Limited (CNTB) — 分析师展望 / 分析师共识目标价为. 基于 5 位分析师评级, 共识为 看涨 — 4 买入, 1 持有.
分析师共识目标价为 $9.00, 上涨空间为 207.2% 相对于当前价格 $2.93.
分析师预估 每股收益(EPS)为 $-0.03 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.28 vs 预期 $-0.03 (不及预期 -736.3%). 2025: 实际 $-1.00 vs 预期 $-0.15 (不及预期 -570.8%). 分析师准确度: 13%.
CNTB 股票 — 12个月价格预测
$9.00
▲ +207.17% 上涨空间
平均目标价
Based on 5 Wall Street analysts offering 12-month price targets for Connect Biopharma Holdings Limited, the price target is $9.00.
平均目标价相对最新价格 $2.93 变动 +207.17%。
CNTB 分析师评级
Buy
基于过去3个月内 5 位分析师对 Connect Biopharma Holdings Limited 的评级
EPS 预测 — CNTB
13%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.28
vs Est –$0.03
▼ 88.0% off
2025
Actual –$1.00
vs Est –$0.15
▼ 85.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — CNTB
13%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.026B
vs Est $0.004B
▲ 86.5% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
